AdaptHealth (NASDAQ:AHCO) executives outlined the company’s second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion.
Chief Executive Officer Suzanne Foster said the company has spen
Electrovaya (NASDAQ:ELVA) reported third-quarter fiscal 2026 revenue of $17.7 million, up from $17.1 million a year earlier, while highlighting a recently announced commercial agreement with Amazon, the launch of its ElvaPulse stationary energy-storage system and progress toward opening its Jamestow
Elbit Systems (NASDAQ:ESLT) reported higher second-quarter revenue, profit and cash flow for 2026, supported by increased demand across Europe, Israel, the U.S. and Asia-Pacific. The defense contractor said its backlog reached a record $32 billion as it continued to add orders from international cus
eToro Group (NASDAQ:ETOR) reported higher second-quarter net contribution and adjusted EBITDA as customer activity shifted toward equities, while the trading and investing platform also announced plans to acquire U.S. broker-dealer TradeZero.
Net contribution rose 9% year over year to $229 million
Big Sky Industrial Inc. Common Stock (NASDAQ:BSIN) reported second-quarter results alongside updates on construction of its Phase 1 industrial gas and carbon management project in Montana, saying commercial operations remain targeted for March 2027.
President and Chief Executive Officer Ryan Smith
Ceragon Networks (NASDAQ:CRNT) reported second-quarter 2026 revenue of $93.9 million, up 14.2% from $82.3 million a year earlier, as demand in India and North America supported growth. The company said bookings reached their highest level since the first quarter of 2024, while first-half bookings an
DarioHealth (NASDAQ:DRIO) reported second-quarter 2026 revenue of $5.2 million, down from $5.6 million in the first quarter and $5.4 million a year earlier, as the company continued to shift away from pharmaceutical services revenue toward recurring B2B2C business.
Chief Financial Officer Chen Fran
Alico (NASDAQ:ALCO) reported higher third-quarter revenue and a return to profitability as the company continued its transition away from citrus operations and toward land management, agricultural leasing and real estate development.
For the three months ended June 30, 2026, Alico recorded total re
Autolus Therapeutics (NASDAQ:AUTL) reported second-quarter 2026 net product revenue of $45.7 million from sales of AUCATZYL, up from $26.2 million in the first quarter and $20.9 million a year earlier, as the company expanded treatment-center access and continued its commercial launch in the United
Bicara Therapeutics (NASDAQ:BCAX) used its second-quarter 2026 earnings call to outline leadership changes, progress in its pivotal head and neck cancer program and plans to expand development of ficerafusp alfa, or FICERA, while reaffirming its cash runway into the first half of 2029.
The company
Stelrad Group (LON:SRAD) reported higher first-half adjusted operating profit and margin despite lower revenue and sales volumes, as the European radiator manufacturer benefited from commercial actions, product mix and cost initiatives in a subdued end-market environment.
Group Chief Executive Trev
